Table 5.
Uni-/multivariate analyses for HSP27 expression in gemcitabine-treated patients
| Variables | No. | HR (95% CI) | P |
|---|---|---|---|
| Univariate analyses* | |||
| HSP27 expression | |||
| Negative | 34 | 1.00 | |
| Positive | 36 | 0.55 (0.32–0.95) | 0.033 |
| Multivariate analyses* | |||
| Adjusted for all† | |||
| HSP27 expression | |||
| Negative | 34 | 1.00 | |
| Positive | 36 | 0.49 (0.27–0.90) | 0.021 |
| Backward elimination | |||
| HSP27 expression | |||
| Negative | 34 | 1.00 | |
| Positive | 36 | 0.46 (0.27–0.79) | 0.006 |
*
Only data for HSP27 are shown. †Adjusted for age, gender, tumour differentiation, tumour size, number of positive nodes and margin status.